ID   DNLJ_ECOLI              Reviewed;         671 AA.
AC   P15042; P78197; P78198;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   15-FEB-2017, entry version 165.
DE   RecName: Full=DNA ligase;
DE            EC=6.5.1.2;
DE   AltName: Full=Polydeoxyribonucleotide synthase [NAD(+)];
GN   Name=ligA; Synonyms=dnaL, lig, lop, pdeC;
GN   OrderedLocusNames=b2411, JW2403;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 1-13 AND
RP   666-671.
RC   STRAIN=K12 / C600 / ATCC 23724 / DSM 3925 / LMG 3041 / NCIB 10222;
RX   PubMed=3018436; DOI=10.1007/BF00330179;
RA   Ishino Y., Shinagawa H., Makino K., Tsunasawa S., Sakiyama F.,
RA   Nakata A.;
RT   "Nucleotide sequence of the lig gene and primary structure of DNA
RT   ligase of Escherichia coli.";
RL   Mol. Gen. Genet. 204:1-7(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   O'Connor M.J., Ally A., Ally D., Zhang X., Robichaud M., Backman K.;
RL   Submitted (APR-1989) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9205837; DOI=10.1093/dnares/4.2.91;
RA   Yamamoto Y., Aiba H., Baba T., Hayashi K., Inada T., Isono K.,
RA   Itoh T., Kimura S., Kitagawa M., Makino K., Miki T., Mitsuhashi N.,
RA   Mizobuchi K., Mori H., Nakade S., Nakamura Y., Nashimoto H.,
RA   Oshima T., Oyama S., Saito N., Sampei G., Satoh Y., Sivasundaram S.,
RA   Tagami H., Takahashi H., Takeda J., Takemoto K., Uehara K., Wada C.,
RA   Yamagata S., Horiuchi T.;
RT   "Construction of a contiguous 874-kb sequence of the Escherichia coli-
RT   K12 genome corresponding to 50.0-68.8 min on the linkage map and
RT   analysis of its sequence features.";
RL   DNA Res. 4:91-113(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND SEQUENCE REVISION.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-90.
RC   STRAIN=PB103;
RX   PubMed=9008158; DOI=10.1016/S0092-8674(00)81838-3;
RA   Hale C.A., de Boer P.A.J.;
RT   "Direct binding of FtsZ to ZipA, an essential component of the septal
RT   ring structure that mediates cell division in E. coli.";
RL   Cell 88:175-185(1997).
RN   [7]
RP   CATALYTIC ACTIVITY, COFACTOR, MUTAGENESIS OF GLU-10; TYR-22; HIS-23;
RP   ASP-32; TYR-35 AND ASP-36, AND ACTIVE SITE.
RX   PubMed=11781321; DOI=10.1074/jbc.M111164200;
RA   Sriskanda V., Shuman S.;
RT   "Conserved residues in domain Ia are required for the reaction of
RT   Escherichia coli DNA ligase with NAD+.";
RL   J. Biol. Chem. 277:9695-9700(2002).
RN   [8]
RP   MUTAGENESIS OF LYS-115; ASP-117; GLY-118; ASP-138; GLU-143; GLY-172;
RP   GLU-173; ASN-198; ARG-200; ARG-208; ARG-277; ASP-285; GLY-286;
RP   VAL-288; LYS-290 AND LYS-314.
RX   PubMed=15671015; DOI=10.1074/jbc.M413685200;
RA   Zhu H., Shuman S.;
RT   "Structure-guided mutational analysis of the nucleotidyltransferase
RT   domain of Escherichia coli NAD+-dependent DNA ligase (LigA).";
RL   J. Biol. Chem. 280:12137-12144(2005).
RN   [9]
RP   MUTAGENESIS OF ARG-333; THR-334; ARG-342; ARG-379; 383-VAL-ILE-384;
RP   446-ARG-ARG-447; GLY-455; ARG-487; GLY-489; GLY-521; GLY-553 AND
RP   ARG-614.
RX   PubMed=18515356; DOI=10.1074/jbc.M802945200;
RA   Wang L.K., Nair P.A., Shuman S.;
RT   "Structure-guided mutational analysis of the OB, HhH, and BRCT domains
RT   of Escherichia coli DNA ligase.";
RL   J. Biol. Chem. 283:23343-23352(2008).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH ZINC IONS; AMP
RP   AND DNA.
RX   PubMed=17466627; DOI=10.1016/j.molcel.2007.02.026;
RA   Nandakumar J., Nair P.A., Shuman S.;
RT   "Last stop on the road to repair: structure of E. coli DNA ligase
RT   bound to nicked DNA-adenylate.";
RL   Mol. Cell 26:257-271(2007).
CC   -!- FUNCTION: DNA ligase that catalyzes the formation of
CC       phosphodiester linkages between 5'-phosphoryl and 3'-hydroxyl
CC       groups in double-stranded DNA using NAD as a coenzyme and as the
CC       energy source for the reaction. It is essential for DNA
CC       replication and repair of damaged DNA.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + (deoxyribonucleotide)(n)-3'-hydroxyl
CC       + 5'-phospho-(deoxyribonucleotide)(m) = (deoxyribonucleotide)(n+m)
CC       + AMP + beta-nicotinamide D-nucleotide.
CC       {ECO:0000269|PubMed:11781321}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:11781321};
CC   -!- SIMILARITY: Belongs to the NAD-dependent DNA ligase family. LigA
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M30255; AAA24071.1; -; Genomic_DNA.
DR   EMBL; M24278; AAA24070.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75464.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA16282.2; -; Genomic_DNA.
DR   EMBL; U74650; AAB42062.1; -; Genomic_DNA.
DR   PIR; B65015; LQECC6.
DR   RefSeq; NP_416906.1; NC_000913.3.
DR   RefSeq; WP_000443661.1; NZ_LN832404.1.
DR   PDB; 2OWO; X-ray; 2.30 A; A=1-671.
DR   PDB; 4GLX; X-ray; 1.90 A; A=1-586.
DR   PDBsum; 2OWO; -.
DR   PDBsum; 4GLX; -.
DR   ProteinModelPortal; P15042; -.
DR   SMR; P15042; -.
DR   BioGrid; 4259672; 128.
DR   DIP; DIP-10098N; -.
DR   IntAct; P15042; 20.
DR   MINT; MINT-204717; -.
DR   STRING; 511145.b2411; -.
DR   PaxDb; P15042; -.
DR   PRIDE; P15042; -.
DR   EnsemblBacteria; AAC75464; AAC75464; b2411.
DR   EnsemblBacteria; BAA16282; BAA16282; BAA16282.
DR   GeneID; 946885; -.
DR   KEGG; ecj:JW2403; -.
DR   KEGG; eco:b2411; -.
DR   PATRIC; 32120205; VBIEscCol129921_2505.
DR   EchoBASE; EB0529; -.
DR   EcoGene; EG10534; ligA.
DR   eggNOG; ENOG4105C77; Bacteria.
DR   eggNOG; COG0272; LUCA.
DR   HOGENOM; HOG000218459; -.
DR   InParanoid; P15042; -.
DR   KO; K01972; -.
DR   OMA; FTAKSPR; -.
DR   PhylomeDB; P15042; -.
DR   BioCyc; EcoCyc:EG10534-MONOMER; -.
DR   BioCyc; MetaCyc:EG10534-MONOMER; -.
DR   BRENDA; 6.5.1.2; 2026.
DR   EvolutionaryTrace; P15042; -.
DR   PRO; PR:P15042; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0003677; F:DNA binding; IDA:EcoCyc.
DR   GO; GO:0003911; F:DNA ligase (NAD+) activity; IDA:EcoliWiki.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070403; F:NAD+ binding; IMP:EcoCyc.
DR   GO; GO:0006288; P:base-excision repair, DNA ligation; IDA:EcoCyc.
DR   GO; GO:0006266; P:DNA ligation; IDA:EcoCyc.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   CDD; cd00027; BRCT; 1.
DR   Gene3D; 3.40.50.10190; -; 1.
DR   HAMAP; MF_01588; DNA_ligase_A; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR018239; DNA_ligase_AS.
DR   InterPro; IPR033136; DNA_ligase_CS.
DR   InterPro; IPR001679; DNAligase.
DR   InterPro; IPR013839; DNAligase_adenylation.
DR   InterPro; IPR013840; DNAligase_N.
DR   InterPro; IPR003583; Hlx-hairpin-Hlx_DNA-bd_motif.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR004150; NAD_DNA_ligase_OB.
DR   InterPro; IPR010994; RuvA_2-like.
DR   InterPro; IPR004149; Znf_DNAligase_C4.
DR   Pfam; PF00533; BRCT; 1.
DR   Pfam; PF01653; DNA_ligase_aden; 1.
DR   Pfam; PF03120; DNA_ligase_OB; 1.
DR   Pfam; PF03119; DNA_ligase_ZBD; 1.
DR   PIRSF; PIRSF001604; LigA; 1.
DR   SMART; SM00292; BRCT; 1.
DR   SMART; SM00278; HhH1; 4.
DR   SMART; SM00532; LIGANc; 1.
DR   SUPFAM; SSF47781; SSF47781; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   SUPFAM; SSF52113; SSF52113; 1.
DR   TIGRFAMs; TIGR00575; dnlj; 1.
DR   PROSITE; PS50172; BRCT; 1.
DR   PROSITE; PS01055; DNA_LIGASE_N1; 1.
DR   PROSITE; PS01056; DNA_LIGASE_N2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   DNA damage; DNA repair; DNA replication; Ligase; Magnesium;
KW   Metal-binding; NAD; Reference proteome; Zinc.
FT   CHAIN         1    671       DNA ligase.
FT                                /FTId=PRO_0000161745.
FT   DOMAIN      593    671       BRCT.
FT   NP_BIND      32     36       NAD. {ECO:0000255|HAMAP-Rule:MF_01588}.
FT   NP_BIND      81     82       NAD. {ECO:0000255|HAMAP-Rule:MF_01588,
FT                                ECO:0000305|PubMed:17466627}.
FT   REGION      330    334       Interaction with target DNA.
FT                                {ECO:0000305|PubMed:17466627}.
FT   REGION      453    458       Interaction with target DNA.
FT                                {ECO:0000305|PubMed:17466627}.
FT   REGION      519    524       Interaction with target DNA.
FT                                {ECO:0000305|PubMed:17466627}.
FT   REGION      551    556       Interaction with target DNA.
FT                                {ECO:0000305|PubMed:17466627}.
FT   ACT_SITE    115    115       N6-AMP-lysine intermediate.
FT                                {ECO:0000255|HAMAP-Rule:MF_01588,
FT                                ECO:0000269|PubMed:11781321}.
FT   METAL       408    408       Zinc. {ECO:0000255|HAMAP-Rule:MF_01588,
FT                                ECO:0000269|PubMed:17466627}.
FT   METAL       411    411       Zinc. {ECO:0000255|HAMAP-Rule:MF_01588,
FT                                ECO:0000269|PubMed:17466627}.
FT   METAL       426    426       Zinc. {ECO:0000255|HAMAP-Rule:MF_01588,
FT                                ECO:0000269|PubMed:17466627}.
FT   METAL       432    432       Zinc. {ECO:0000255|HAMAP-Rule:MF_01588,
FT                                ECO:0000269|PubMed:17466627}.
FT   BINDING     113    113       NAD. {ECO:0000255|HAMAP-Rule:MF_01588,
FT                                ECO:0000305|PubMed:17466627}.
FT   BINDING     136    136       NAD. {ECO:0000255|HAMAP-Rule:MF_01588,
FT                                ECO:0000305|PubMed:17466627}.
FT   BINDING     173    173       NAD. {ECO:0000255|HAMAP-Rule:MF_01588}.
FT   BINDING     290    290       NAD. {ECO:0000255|HAMAP-Rule:MF_01588,
FT                                ECO:0000305|PubMed:17466627}.
FT   BINDING     314    314       NAD. {ECO:0000255|HAMAP-Rule:MF_01588}.
FT   SITE        487    487       Interaction with target DNA.
FT                                {ECO:0000305|PubMed:17466627}.
FT   SITE        492    492       Interaction with target DNA.
FT                                {ECO:0000305|PubMed:17466627}.
FT   MUTAGEN      10     10       E->A: No effect.
FT                                {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      22     22       Y->A,S: Reduces nick joining activity by
FT                                99.9%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      22     22       Y->F: Reduces nick joining activity by
FT                                91%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      23     23       H->A,Y: Reduces nick joining activity by
FT                                90%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      32     32       D->A,E: Reduces nick joining activity by
FT                                99%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      32     32       D->N: Reduces nick joining activity by
FT                                91%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      35     35       Y->A: Reduces nick joining activity by
FT                                98%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      35     35       Y->F: Reduces nick joining activity by
FT                                77%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      35     35       Y->S: Reduces nick joining activity by
FT                                99.9%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      36     36       D->A: Reduces nick joining activity by
FT                                99.8%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      36     36       D->E: Reduces nick joining activity by
FT                                96%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN      36     36       D->N: Reduces nick joining activity by
FT                                88%. {ECO:0000269|PubMed:11781321}.
FT   MUTAGEN     115    115       K->Q,R: Reduces nick joining activity by
FT                                99.9%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     117    117       D->E: Reduces nick joining activity by
FT                                97%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     117    117       D->N: Reduces nick joining activity by
FT                                99.9%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     118    118       G->A: Reduces nick joining activity by
FT                                99.9%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     138    138       D->A: Reduces nick joining activity by
FT                                63%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     143    143       E->A: Reduces nick joining activity by
FT                                48%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     172    172       G->A: Reduces nick joining activity by
FT                                64%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     173    173       E->A,D,Q: Reduces nick joining activity
FT                                by 99.9%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     198    198       N->A: Reduces nick joining activity by
FT                                74%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     200    200       R->A,K,Q: Reduces nick joining activity
FT                                by 99.9%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     208    208       R->A,K,Q: Reduces nick joining activity
FT                                by 99%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     277    277       R->A: Reduces nick joining activity by
FT                                99%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     285    285       D->E: Reduces nick joining activity by
FT                                96%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     285    285       D->N: Reduces nick joining activity by
FT                                99%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     286    286       G->A: Reduces nick joining activity by
FT                                86%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     288    288       V->A: Reduces nick joining activity by
FT                                25%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     290    290       K->A: Reduces nick joining activity by
FT                                87%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     314    314       K->Q: Reduces nick joining activity by
FT                                99%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     314    314       K->R: Reduces nick joining activity by
FT                                95%. {ECO:0000269|PubMed:15671015}.
FT   MUTAGEN     333    333       R->A,Q: Reduces nick joining activity by
FT                                over 95%. Abolishes nick joining
FT                                activity; when associated with A-334.
FT                                {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     334    334       T->A: Abolishes nick joining activity;
FT                                when associated with A-333.
FT                                {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     342    342       R->A: Reduces nick joining activity by
FT                                80%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     379    379       R->A,Q: Reduces nick joining activity by
FT                                over 95%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     383    384       VI->AA: Reduces nick joining activity by
FT                                95%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     446    447       RR->AA: Reduces nick joining activity by
FT                                95%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     455    455       G->A: Reduces nick joining activity by
FT                                50%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     455    455       G->D,V: Reduces nick joining activity by
FT                                95%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     487    487       R->A: Reduces nick joining activity by
FT                                over 90%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     489    489       G->D,V: Reduces nick joining activity by
FT                                95%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     521    521       G->A: Reduces nick joining activity by
FT                                95%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     521    521       G->D,V: Loss of nick joining activity.
FT                                {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     553    553       G->D,V: Reduces nick joining activity by
FT                                95%. {ECO:0000269|PubMed:18515356}.
FT   MUTAGEN     614    614       R->A: Reduces nick joining activity by
FT                                85%. {ECO:0000269|PubMed:18515356}.
FT   CONFLICT     69     69       A -> R (in Ref. 1; AAA24071).
FT                                {ECO:0000305}.
FT   HELIX         4     24       {ECO:0000244|PDB:4GLX}.
FT   STRAND       28     30       {ECO:0000244|PDB:4GLX}.
FT   HELIX        34     48       {ECO:0000244|PDB:4GLX}.
FT   HELIX        50     52       {ECO:0000244|PDB:4GLX}.
FT   HELIX        58     60       {ECO:0000244|PDB:4GLX}.
FT   STRAND       72     74       {ECO:0000244|PDB:4GLX}.
FT   STRAND       83     85       {ECO:0000244|PDB:2OWO}.
FT   HELIX        88    100       {ECO:0000244|PDB:4GLX}.
FT   STRAND      102    104       {ECO:0000244|PDB:2OWO}.
FT   STRAND      110    126       {ECO:0000244|PDB:4GLX}.
FT   STRAND      129    135       {ECO:0000244|PDB:4GLX}.
FT   STRAND      139    144       {ECO:0000244|PDB:4GLX}.
FT   HELIX       146    149       {ECO:0000244|PDB:4GLX}.
FT   STRAND      161    163       {ECO:0000244|PDB:4GLX}.
FT   STRAND      166    175       {ECO:0000244|PDB:4GLX}.
FT   HELIX       178    190       {ECO:0000244|PDB:4GLX}.
FT   HELIX       199    207       {ECO:0000244|PDB:4GLX}.
FT   HELIX       212    216       {ECO:0000244|PDB:4GLX}.
FT   STRAND      221    233       {ECO:0000244|PDB:4GLX}.
FT   HELIX       239    248       {ECO:0000244|PDB:4GLX}.
FT   STRAND      258    262       {ECO:0000244|PDB:4GLX}.
FT   HELIX       263    276       {ECO:0000244|PDB:4GLX}.
FT   HELIX       277    279       {ECO:0000244|PDB:4GLX}.
FT   STRAND      280    282       {ECO:0000244|PDB:4GLX}.
FT   STRAND      284    293       {ECO:0000244|PDB:4GLX}.
FT   HELIX       294    300       {ECO:0000244|PDB:4GLX}.
FT   STRAND      304    313       {ECO:0000244|PDB:4GLX}.
FT   STRAND      319    331       {ECO:0000244|PDB:4GLX}.
FT   STRAND      335    348       {ECO:0000244|PDB:4GLX}.
FT   STRAND      351    357       {ECO:0000244|PDB:4GLX}.
FT   HELIX       361    367       {ECO:0000244|PDB:4GLX}.
FT   STRAND      374    380       {ECO:0000244|PDB:4GLX}.
FT   TURN        381    383       {ECO:0000244|PDB:4GLX}.
FT   STRAND      384    390       {ECO:0000244|PDB:4GLX}.
FT   HELIX       392    394       {ECO:0000244|PDB:4GLX}.
FT   TURN        409    411       {ECO:0000244|PDB:4GLX}.
FT   STRAND      414    416       {ECO:0000244|PDB:4GLX}.
FT   STRAND      425    427       {ECO:0000244|PDB:4GLX}.
FT   HELIX       429    431       {ECO:0000244|PDB:4GLX}.
FT   HELIX       433    444       {ECO:0000244|PDB:4GLX}.
FT   TURN        446    449       {ECO:0000244|PDB:4GLX}.
FT   HELIX       456    464       {ECO:0000244|PDB:4GLX}.
FT   HELIX       471    475       {ECO:0000244|PDB:4GLX}.
FT   HELIX       479    483       {ECO:0000244|PDB:4GLX}.
FT   HELIX       490    503       {ECO:0000244|PDB:4GLX}.
FT   HELIX       508    514       {ECO:0000244|PDB:4GLX}.
FT   HELIX       522    532       {ECO:0000244|PDB:4GLX}.
FT   HELIX       535    540       {ECO:0000244|PDB:4GLX}.
FT   HELIX       543    546       {ECO:0000244|PDB:4GLX}.
FT   HELIX       554    565       {ECO:0000244|PDB:4GLX}.
FT   HELIX       567    578       {ECO:0000244|PDB:4GLX}.
SQ   SEQUENCE   671 AA;  73606 MW;  DD2BDC64D8E65256 CRC64;
     MESIEQQLTE LRTTLRHHEY LYHVMDAPEI PDAEYDRLMR ELRELETKHP ELITPDSPTQ
     RVGAAPLAAF SQIRHEVPML SLDNVFDEES FLAFNKRVQD RLKNNEKVTW CCELKLDGLA
     VSILYENGVL VSAATRGDGT TGEDITSNVR TIRAIPLKLH GENIPARLEV RGEVFLPQAG
     FEKINEDARR TGGKVFANPR NAAAGSLRQL DPRITAKRPL TFFCYGVGVL EGGELPDTHL
     GRLLQFKKWG LPVSDRVTLC ESAEEVLAFY HKVEEDRPTL GFDIDGVVIK VNSLAQQEQL
     GFVARAPRWA VAFKFPAQEQ MTFVRDVEFQ VGRTGAITPV ARLEPVHVAG VLVSNATLHN
     ADEIERLGLR IGDKVVIRRA GDVIPQVVNV VLSERPEDTR EVVFPTHCPV CGSDVERVEG
     EAVARCTGGL ICGAQRKESL KHFVSRRAMD VDGMGDKIID QLVEKEYVHT PADLFKLTAG
     KLTGLERMGP KSAQNVVNAL EKAKETTFAR FLYALGIREV GEATAAGLAA YFGTLEALEA
     ASIEELQKVP DVGIVVASHV HNFFAEESNR NVISELLAEG VHWPAPIVIN AEEIDSPFAG
     KTVVLTGSLS QMSRDDAKAR LVELGAKVAG SVSKKTDLVI AGEAAGSKLA KAQELGIEVI
     DEAEMLRLLG S
//
